MEA Header

Eye News & Views

a newsletter for Medical Professionals

October 2014

In This Issue
Stay Connected

Find us on Google+

Like us on Facebook

Follow us on Twitter

View our profile on LinkedIn

Find us on Pinterest

Visit our blog

View our videos on YouTube

MEA Happenings

Cynthia Matossian, MD, FACS presented her Malyugin Ring Insertion with Visco-Assist Technique at the American-European Congress of Ophthalmic Surgery (AECOS) Summer Meeting in Deer Park, Utah in July, 2014.

Cynthia Matossian, MD was named the ShoutMD Ambassador for Physician Recommended Nutriceuticals in August, 2014.

Ilya Rozenbaum, MD
spoke to seniors at the Pine Run Community in Doylestown, PA on cataracts and glaucoma in October, 2014.

Cynthia Matossian, MD, FACS was featured during a roundtable webinar sponsored by Alphaeon, offering her expertise on nutritional supplements in August, 2014.

Cynthia Matossian, MD, FACS was featured in the July/August issue of Ophthalmic Professional in an article entitled "How a Perfectionist Cuts Chair Time." Please click here to view the article.

Cynthia Matossian, MD, FACS led several live webinars and round table discussions for Ophthalmologists, Optometrists, and other eye care professionals across the country.


Cynthia Matossian, MD, FACS presented a variety of lectures on ophthalmic products, medications and/or surgical techniques throughout the United States to many groups of ophthalmologists.
Cynthia Matossian, MD Publishes Article on the use of OPD III for Cataract Surgical Planning

"A Corneal Analyzer for Advanced Surgical Planning," an article written by Cynthia Matossian, MD was published in the September 2014 edition of Cataract & Refractive Surgery Today (CRST). In this article, Dr. Matossian describes how she uses the OPD III technology to customize implant selection for her patients.

To view this journal article, please click here.

Month, Year
Dr. Matossian Uses a New Sealant for High Risk Patients in Cataract Surgery

In the August 2014 issue of Cataract & Refractive Surgery Today (CRST), Cynthia Matossian, MD described her use of ReSure® Sealant in high risk patients at the time of cataract surgery. Not only does this technology save time, but it demonstrated superior outcomes compared to stromal hydration in clinical trials.

Dr. Matossian is currently involved in a clinical study evaluating the use of ReSure® Sealant in high-risk patients, and will publish the results soon.

To view this journal article, please click here.

Month, Year

Dr. Matossian Blogs about Tear

Osmolarity

Cynthia Matossian, MD, FACS has been blogging about her use of Tear Osmolarity. The four issues in this series cover the following topics:

  • The Matossian Eye Associates Tear Osmolarity Protocol. Click here for the article.
  • How to Implement Tear Osmolarity Testing in a Practice. Click here for the article.
  • What to do with the Information Obtained from Tear Osmolarity Testing. Click here for the article.
  • The Importance of Tracking Tear Osmolarity Numbers from Visit to Visit. Click here for the article.

Published in TearLab's The Dry Eye Review: In My Practice, this four-part series outlines the Tear Osmolarity process and its potential value to both patient and practice.


Month, Year
MEA is Active in a Variety of Clinical Studies
  • Lotemax (Bausch + Lomb) vs. Vehicle Gel for Inflammation/Pain Post-Cataract Surgery. We are about to begin this study.
  • Tri-Moxi-Vanc (Imprimis Pharmaceuticals) Injection Post-Cataract Surgery and its Effect on Corneal Endothelial Cells. We are about to begin this study.
  • WHITESTAR Signature® (Abbott Medical Optics) with Two Different Tips in Cataract Surgery. We have started to enroll patients into this study.
  • Tecnis Toric (Abbott Medical Optics) 1-Piece IOL Registry. We are actively enrolling patients into this study.
  • Hoffer H5 IOL Formula. This study is in the data collection phase where gender and race are factored in IOL power calculation formulas.
  • The Influence of the PRN Dry Eye Omega 3 Nutritional Regimen in Tear Osmolarity. We are almost done enrolling patients into this study.
  • Evaluation of ReSure® Sealant (Ocular Therapeutix) in High Risk Patients. We are over half-way done enrolling patients into this study.
  • Alzheimer's Disease Trial (G. Gilbus, MD with Capital Health Neurosciences). We are about to begin this study.
  • Investigation of trabecular micro-bypass stent system in conjunction with Cataract Surgery (Glaukos). We are about to begin this study.
  • Blimatoprost Preservative-Free Intracameral Delivery for Patients with OAG and OHT (Allergan). We are about to begin this study.
  • Lenstec HD and HDO IOLs with Monte Carlo Application. We are about to begin a retrospective analysis of our data.
  • IPL Study (collaboration with Duke Eye Center). We are performing a retrospective data analysis of our outcomes.
  • Post-Market IOL Study (Alcon). We have started this blue filter study.
Month, Year
Dr. Matossian Discusses the Advantages of an Internet Manager

In the August 2014 issue of Ophthalmology Management: The Enlightened Office, Cynthia Matossian, MD outlined the many ways having an on-staff Internet Manager has boosted the online presence of Matossian Eye Associates and has been a valuable investment for the practice.

Please click here to read the article.



Month, Year
Dr. Matossian Interviewed about NSAIDs by OSN

During a recent interview by Ocular Surgery News, Cynthia Matossian, MD, FACS contributed her thoughts on the importance of choosing the proper NSAID following cataract surgery to reduce pain and inflammation.
To view the video interview, please click here.

To read the interview, please click
here.

Month, Year

Matossian Eye Associates

Welcomes Dr. Henry Lee

Matossian Eye Associates

welcomes Henry Lee, MD.

Dr. Lee is a board-certified ophthalmologist with additional fellowship training in oculofacial plastic and reconstructive surgery. He specializes in functional and cosmetic procedures involving the eyelids, the tear drainage apparatus, and the orbit/eye socket.


Dr. Lee is originally from New Jersey and received his medical degree from the Mount Sinai School of Medicine in New York City. He completed his residency at the University of Pennsylvania Scheie Eye Institute in Philadelphia. Dr. Lee then completed two additional years of subspecialty training in an American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS)-sponsored fellowship in Seattle, WA, where he gained much experience with minimally-invasive cosmetic procedures such as dermal filler and botulinum toxin injections. Dr. Lee will working at MEA on a part-time basis in both the Doylestown, PA and the Hopewell, NJ offices.


Month, Year
Dr. Matossian Discusses How Clinical Trials Help Your Practice Stand Out

In the July 2014 edition of Ophthalmology Management, Cynthia Matossian, MD, FACS wrote an article entitled "How Clinical Trials can Help Differentiate Your Practice." In this article, Dr. Matossian explains how participating in clinical trials not only sets a practice apart from the rest, but helps them keep on the cutting edge of technology, medicine, and patient care.

Please click here to view this article.

Month, Year
Dr. Rozenbaum Employs OPD III to Facilitate IOL Selection

null
In the September 2014 edition of Cataract & Refractive Surgery Today (CRST), Ilya Rozenbaum, MD discussed his use of OPD III technology to achieve accurate implant calculations. He discusses the various measurements the technology provides and how they can best be put to use to achieve optimal surgical outcomes.

Please click here to view this article.
Month, Year

Dr. Matossian Discusses How She Utilizes Technology in Her Practice

Cynthia Matossian, MD, FACS published an article in the September 2014 edition of Cataract & Refractive Surgery Today Europe in which she describes the various digital resources that she has incorporated into the practice. From online reputation management to patient education, Dr. Matossian shares her experience utilizing digital resources to maximize the online presence of the practice.

To view this journal article, please click here.

Month, Year
About Us

Matossian Eye Associates
was founded in 1987. Our professional objective is to provide every patient with excellent eye care in a personalized and caring manner.

Our practice offers a complete range of preventive and corrective eye care and surgery, using the most advanced technology available for detection and treatment of eye disease.

Footer-logo